Nuwellis Inc
For the period ended Sep 30, 2024. Filed Nov 12, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 12, 2024
NUWE$5.24+6.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
Cash Flows
| 2024 | 2023 | |
|---|---|---|
| Operating Activities: | ||
| Net loss | $(9,697) | $(14,700) |
| Adjustments to reconcile net loss to cash flows used in operating activities: | ||
| Depreciation and amortization | 227 | 253 |
| Stock-based compensation expense | 374 | 513 |
| Change in fair value of warrant liability | (4,602) | 755 |
| Warrant financing costs | 5,607 | — |
| Net realized gain on marketable securities | — | (65) |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | 658 | (19) |
| Inventory, net | 120 | 325 |
| Other current assets | (275) | (551) |
| Other assets and liabilities | (13) | (16) |
| Accounts payable and accrued expenses | (486) | (1,678) |
| Net cash used in operating activities | (8,087) | (15,183) |
| Investing Activities: | ||
| Proceeds from sale of marketable securities | — | 578 |
| Additions to intangible assets | — | (99) |
| Purchases of property and equipment | (37) | (185) |
| Net cash provided by (used in) investing activities | (37) | 294 |
| Financing Activities: | ||
| Issuance of common stock from offering | 2,403 | — |
| Proceeds from the exercise of Series J Convertible Preferred Warrants | 501 | — |
| Proceeds from the exercise of April 2024 Warrants | 1,182 | — |
| Issuance of July and August 2024 Common Stock and Warrants | 2,160 | — |
| Proceeds from ATM stock offerings, net | — | 2,108 |
| Payments on finance lease liability | — | (20) |
| Net cash provided by financing activities | 6,246 | 2,088 |
| Effect of exchange rate changes on cash | (15) | (6) |
| Net decrease in cash and cash equivalents | (1,893) | (12,807) |
| Cash and cash equivalents - beginning of period | 3,800 | 17,737 |
| Cash and cash equivalents - end of period | $1,907 | $4,930 |
| Supplemental cash flow information | ||
| Non-cash impact of conversion of warrants to common stock | $— | $6,868 |
| Reclassification of April 2024 warrants to equity | $4,217 | $— |
| Issuance of Series J Preferred Stock for exercise of warrants | $1,857 | $— |
| Issuance of Common Stock for conversion of Series J Preferred Stock | $1,535 | $— |
| Deemed dividend on Series J Preferred Stock | $541 | $— |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.